Veterinary Medicines

Euthasol vet. 400 mg/ml, solution for injection

Authorised
  • Pentobarbital sodium
Download as PDF

Product identification

Medicine name:
Euthasol vet. 400 mg/ml, solution for injection
Euthasol vet. 400 mg/ml šķīdums injekcijām suņiem, kaķiem, grauzējiem, trušiem, liellopiem, aitām, kazām, zirgiem un ūdelēm
Active substance:
  • Pentobarbital sodium
Target species:
  • Cattle
  • Dog
  • Goat
  • Sheep
  • Horse (non food-producing)
  • Cat
  • Mink
  • Chinchilla
  • Gerbil
  • Guinea pig
  • Hamster
  • Mouse
  • Rat
  • Rabbit (non food-producing)
Route of administration:
  • Intracardiac use
  • Intravenous use

Product details

Active substance and strength:
  • Pentobarbital sodium
    400.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intracardiac use
    • Cattle
    • Dog
    • Goat
    • Sheep
    • Horse (non food-producing)
    • Cat
    • Mink
    • Chinchilla
    • Gerbil
    • Guinea pig
    • Hamster
    • Mouse
    • Rat
    • Rabbit (non food-producing)
  • Intravenous use
    • Cattle
    • Dog
    • Goat
    • Sheep
    • Horse (non food-producing)
    • Cat
    • Mink
    • Chinchilla
    • Gerbil
    • Guinea pig
    • Hamster
    • Mouse
    • Rat
    • Rabbit (non food-producing)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • 100 ml colourless type I glass vial with a light grey bromobutyl rubber stopper and an aluminium cap.
  • 250 ml colourless type I glass vial with a dark grey bromobutyl rubber stopper and an aluminium cap.
  • 100 ml colourless type II glass vial with a light grey bromobutyl rubber stopper and an aluminium cap. [HISTORICAL]
  • 250 ml colourless type II glass vial with a dark grey bromobutyl rubber stopper and an aluminium cap. [HISTORICAL]

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/12/0018
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0618/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
Latvian (PDF)
Published on: 28/05/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/05/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/05/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."